Expanded access to inhaled nitric oxide for pulmonary hypertension with lung scarring
Part of Heart & circulation, Lungs & breathing clinical trials.
This study provides access to an experimental treatment called inhaled nitric oxide (delivered by the INOpulse device) for people with pulmonary hypertension caused by lung scarring. It aims to see if this treatment can help improve their condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have pulmonary hypertension linked to a lung condition (like pulmonary fibrosis) and not be eligible for other clinical trials.
- You need to be willing to use the INOpulse device for up to 24 hours a day.
- If you could become pregnant, you must have a negative pregnancy test and use birth control.
- You must not be taking riociguat or certain other medicines.
- You must not need a ventilator or CPAP machine for breathing support.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether inhaled nitric oxide gas can help full-term newborns who have severe breathing problems and high blood pressure in their lungs. It aims to improve oxygen levels and reduce the need for more intensive support.
This trial tests whether giving a gas called inhaled nitric oxide helps newborns with a congenital diaphragmatic hernia breathe better and improve lung blood pressure. It's a type of treatment often used to help with lung problems in babies.
This study tests an inhaled medication called mosliciguat for people with pulmonary hypertension (high blood pressure in the lungs) caused by certain types of lung scarring. It may help improve your ability to exercise and manage symptoms.
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
This trial tests whether inhaled nitric oxide can help people with severe obesity who are on a breathing machine because their lungs aren't getting enough oxygen. It aims to see if this treatment improves oxygen levels and recovery.
This study tests an inhaled gas (iNO300) given through your breathing tube to improve oxygen levels in critically ill patients with pneumonia. You may qualify if you are on a ventilator and have been diagnosed with pneumonia within the last 3 days.
Hear when a new Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.